Fate Therapeutics, Inc.

NASDAQ:FATE

1.04 (USD) • At close May 9, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20242023202220212020201920182017201620152014201320122011
Assets:
Current Assets:
Cash & Cash Equivalents 36.05641.8761.333133.583167.34799.814190.51488.95288.60964.80949.10154.0369.0876.387
Short Term Investments 243.012273.305374.894482.327315.569121.61310.49311.9973.50300000
Cash and Short Term Investments 279.068315.175436.227615.91482.916221.427201.007100.94992.11264.80949.10154.0369.0876.387
Net Receivables 3.5391.82638.488.6765.51500.50000000
Inventory 00000000000000
Other Current Assets 9.30214.53927.3678.8264.3924.6623.6893.2942.4221.6861.5311.230.7060.301
Total Current Assets 291.909331.54502.074633.412494.323227.089205.196102.59693.32365.65249.87254.6519.7936.688
Non-Current Assets:
Property, Plant & Equipment, Net 110.892158.51166.06970.7267.08422.7525.1252.551.5792.161.20.811.1611.042
Goodwill 00000000000000
Intangible Assets 00000000000000
Goodwill and Intangible Assets 00000000000000
Long Term Investments 27.6570.984.942100.66428.73339.442.1850.1220.1220.1220000
Tax Assets 00000000000000
Other Non-Current Assets 10.23615.186132.476116.65932.31712.9930.5260.0240.0240.0240.1320.1220.1220.122
Total Non-Current Assets 148.785174.677203.487288.043128.13475.1857.8362.6961.7252.3061.3320.9321.2831.164
Total Assets 440.694506.217705.561921.455622.457302.274213.032105.29295.04867.95851.20455.58311.0767.852
Liabilities & Equity:
Current Liabilities:
Account Payables 9.3654.7198.2658.6126.2835.8224.2051.6780.9340.9960.6450.6821.2281.863
Short Term Debt 7.4166.17611.25611.1546.713.3842.43808.1876.5541.5461.7321.9411.248
Tax Payables 00000000000000
Deferred Revenue 0.3930.68542.22621.48321.1442.7877.5882.1052.1052.4012.262.0920.0630.146
Other Current Liabilities 21.34827.51452.30440.03551.42715.81313.0327.2663.9612.4942.392.1861.3670.221
Total Current Liabilities 38.52239.094114.05181.28485.56427.80627.26311.04915.18713.4414.5814.64.853.675
Non-Current Liabilities:
Long Term Debt 097.36103.71109.24193.94325.23512.44614.8082.50110.68818.08301.7323.591
Deferred Revenue Non-Current 00027.12446.0213.7757.50.7242.8294.9340000
Deferred Tax Liabilities Non-Current 00024.16811.684000000000
Other Non-Current Liabilities 83.4461.3463.86124.96812.4840.7025.3541.5221.3770.8570.20.13557.31951.269
Total Non-Current Liabilities 83.44698.706107.571161.333152.44829.71225.317.0546.70716.47918.2830.13559.05154.86
Total Liabilities 121.968137.8221.622242.617238.01257.51852.56328.10321.89429.9222.8644.73563.90158.535
Equity:
Preferred Stock 0.0030.0030.0030.0030.0030.0030.0030.0030.00300056.5260
Common Stock 0.1140.0990.0970.0960.0880.0760.0650.0530.0410.0290.0210.020.0010.001
Retained Earnings -1,397.994-1,211.732-1,050.804-769.083-556.932-383.545-285.396-218.798-175.846-142.384-112.392-86.509-65.615-51.376
Accumulated Other Comprehensive Income/Loss 0.2680.015-1.854-0.7620.070.022-0.002-0.003-0.001-3.472-2.787-2.296-1.749-1.16
Other Total Stockholders Equity 1,716.3351,580.0321,536.4971,448.584941.216628.2445.799295.934248.957180.393140.711137.337-43.7371.852
Total Shareholders Equity 318.726368.417483.939678.838384.445244.756160.46977.18973.15438.03828.3450.848-52.825-50.683
Total Equity 318.726368.417483.939678.838384.445244.756160.46977.18973.15438.03828.3450.848-52.825-50.683
Total Liabilities & Shareholders Equity 440.694506.217705.561921.455622.457302.274213.032105.29295.04867.95851.20455.58311.0767.852